Oral Cancer Drug for Squamous Cell Carcinoma
What You Need to Know Before You Apply
What is the purpose of this trial?
Study Design: A Window of Opportunity Clinical Trial. This study design permits examination of effects of an oral agent on cancer patients during the "window" between diagnosis of their cancer and their definitive cancer surgery. Similar to a phase 0 study, the trial design permits examination of the biologic effects of an agent; in this study pharmacokinetic properties will be examined.
Who Is on the Research Team?
Stuart J. Wong, MD
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
Adults diagnosed with oral cavity squamous cell cancer, fit for surgery (stage II-IVA), and have good organ function. They must not be pregnant or breastfeeding, agree to use contraception if of childbearing potential, and can't have had certain prior treatments for oral SCC. No severe comorbidities like uncontrolled heart disease or severe COPD.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the natural botanical compound ATB-KAC and provide blood and saliva samples during administration
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Antitumor B KAC
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor